Reviscon Mono PFS 20 mg/ml Injection 2.4 ml

Reviscon Mono PFS 20 mg/ml Injection 2.4 ml is a non-steroidal anti-inflammatory drugs (NSAIDs) used in the treatment of knee pain due to osteoarthritis. It is a degenerative joint disease in which the two ends of the joints come together due to the breakdown of a protective covering of cartilage.

Reviscon Mono PFS 20 mg/ml Injection 2.4 ml contains Sodium hyaluronate, which works by restoring synovial fluid in the knee that helps to lubricate and cushion the joint during movement. Thereby it reduces pain.

Reviscon Mono PFS 20 mg/ml Injection 2.4 ml will be administered by a healthcare professional; do not self-administer. In some cases, you may experience certain common side effects such as pain, swelling, redness, and warmth at the injection site or fluid in the joint. If the side effects persist or worsen, please consult your doctor.

If you are allergic to Sodium hyaluronate or products from birds such as eggs, feathers and poultry, inform your doctor before receiving Reviscon Mono PFS 20 mg/ml Injection 2.4 ml. Reviscon Mono PFS 20 mg/ml Injection 2.4 ml is not recommended for children, pregnant or breastfeeding woman and should be used with caution in patients with pre-existing chondrocalcinosis (accumulation of calcium salts in hyaline cartilage or fibrocartilage) as it may lead to an acute attack of the condition.

Reviscon Mono PFS 20 mg/ml Injection 2.4 ml is indicated in the treatment of Osteoarthritis. The detailed uses are as follows:

• Treats osteoarthritis: Reviscon Mono PFS 20 mg/ml Injection 2.4 ml helps manage osteoarthritis, a joint condition. It works by restoring synovial fluid in the knee that helps to lubricate and cushion the joint during movement. 

• Follow your doctor's instructions on the dosage and timing of this medication to ensure safety.
• Reviscon Mono PFS 20 mg/ml Injection 2.4 ml will be administered by the doctor or healthcare professional.
• Do not self-administer.

• Reviscon Mono PFS 20 mg/ml Injection 2.4 ml contains Sodium hyaluronate, a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of knee pain due to osteoarthritis.
• Reviscon Mono PFS 20 mg/ml Injection 2.4 ml is mainly used in patients who have failed to respond adequately to simple painkillers or physical therapy and exercise.
• Reviscon Mono PFS 20 mg/ml Injection 2.4 ml works by restoring synovial fluid in the knee that helps to lubricate and cushion the joint during movement. Thereby it reduces pain by decreasing friction in the joints.
• Reviscon Mono PFS 20 mg/ml Injection 2.4 ml is administered by a health professional.

• Inform your doctor before receiving Reviscon Mono PFS 20 mg/ml Injection 2.4 ml if you are allergic to Sodium hyaluronate or products from birds such as eggs, feathers and poultry.
• If you are a pregnant or breastfeeding woman, inform your doctor before receiving Reviscon Mono PFS 20 mg/ml Injection 2.4 ml.
• Reviscon Mono PFS 20 mg/ml Injection 2.4 ml is not recommended for children as safety and effectiveness have not been established.
• Reviscon Mono PFS 20 mg/ml Injection 2.4 ml should be used with caution in patients with pre-existing chondrocalcinosis (accumulation of calcium salts in hyaline cartilage or fibrocartilage) as it may lead to an acute attack of the condition.
• Avoid activities such as tennis, heavy lifting, jogging, or standing on your feet for a long time immediately after receiving Reviscon Mono PFS 20 mg/ml Injection 2.4 ml and for the next 48 hours.